234 related articles for article (PubMed ID: 17637014)
21. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
[TBL] [Abstract][Full Text] [Related]
22. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
[TBL] [Abstract][Full Text] [Related]
23. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Caldwell GW; Easlick SM; Gunnet J; Masucci JA; Demarest K
J Mass Spectrom; 1998 Jul; 33(7):607-14. PubMed ID: 9692244
[TBL] [Abstract][Full Text] [Related]
24. In Vitro and In Situ Characterization of Triterpene Glycosides From Cimicifuga racemosa Extract.
Disch L; Forsch K; Siewert B; Drewe J; Fricker G
J Pharm Sci; 2017 Dec; 106(12):3642-3650. PubMed ID: 28827038
[TBL] [Abstract][Full Text] [Related]
25. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
26. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
Cao X; Li H; Wang M; Ren X; Deng Y
Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide.
Haltner-Ukomadu E; Gureyeva S; Burmaka O; Goy A; Mueller L; Kostyuk G; Margitich V
Sci Pharm; 2018 Jan; 86(1):. PubMed ID: 29324660
[TBL] [Abstract][Full Text] [Related]
28. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
Incecayir T; Tsume Y; Amidon GL
Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720
[TBL] [Abstract][Full Text] [Related]
30. Biopharmaceutical characterization of sotalol-containing oral immediate release drug products.
Alt A; Potthast H; Moessinger J; Sickmüller B; Oeser H
Eur J Pharm Biopharm; 2004 Jul; 58(1):145-50. PubMed ID: 15207548
[TBL] [Abstract][Full Text] [Related]
31. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver.
Smetanová L; Stĕtinová V; Svoboda Z; Kvetina J
Acta Medica (Hradec Kralove); 2011; 54(1):3-8. PubMed ID: 21542416
[TBL] [Abstract][Full Text] [Related]
32. Link between drug absorption solubility and permeability measurements in Caco-2 cells.
Pade V; Stavchansky S
J Pharm Sci; 1998 Dec; 87(12):1604-7. PubMed ID: 10189274
[TBL] [Abstract][Full Text] [Related]
33. Leveraging BCS in Development: A Case Study.
Hoaglund Hyzer CS; Fadda HM; Rodriguez JO; Aburub A
Mol Pharm; 2015 Oct; 12(10):3685-90. PubMed ID: 26365521
[TBL] [Abstract][Full Text] [Related]
34. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
[TBL] [Abstract][Full Text] [Related]
35. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
Zaki NM; Artursson P; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997
[TBL] [Abstract][Full Text] [Related]
36. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
37. Optimizing solubility and permeability of a biopharmaceutics classification system (BCS) class 4 antibiotic drug using lipophilic fragments disturbing the crystal lattice.
Tehler U; Fagerberg JH; Svensson R; Larhed M; Artursson P; Bergström CA
J Med Chem; 2013 Mar; 56(6):2690-4. PubMed ID: 23432334
[TBL] [Abstract][Full Text] [Related]
38. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol.
Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A
Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251
[TBL] [Abstract][Full Text] [Related]
39. Classification of loratadine based on the biopharmaceutics drug classification concept and possible in vitro-in vivo correlation.
Khan MZ; Rausl D; Zanoski R; Zidar S; Mikulcić JH; Krizmanić L; Eskinja M; Mildner B; Knezević Z
Biol Pharm Bull; 2004 Oct; 27(10):1630-5. PubMed ID: 15467209
[TBL] [Abstract][Full Text] [Related]
40. Comparing multilabel classification methods for provisional biopharmaceutics class prediction.
Newby D; Freitas AA; Ghafourian T
Mol Pharm; 2015 Jan; 12(1):87-102. PubMed ID: 25397721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
